(3R)-N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(5-methyl-1H-indazol-7-yl)sulfonyl]pyrrolidine-3-carboxamide

C23H26ClN5O4S — CID 171442744

IUPAC(3R)-N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(5-methyl-1H-indazol-7-yl)sulfonyl]pyrrolidine-3-carboxamide
SMILESCc1cc(S(=O)(=O)N2CC[C@@H](C(=O)Nc3ccc(N4CCOCC4)c(Cl)c3)C2)c2[nH]ncc2c1
InChIInChI=1S/C23H26ClN5O4S/c1-15-10-17-13-25-27-22(17)21(11-15)34(31,32)29-5-4-16(14-29)23(30)26-18-2-3-20(19(24)12-18)28-6-8-33-9-7-28/h2-3,10-13,16H,4-9,14H2,1H3,(H,25,27)(H,26,30)/t16-/m1/s1
InChIKeyOQOHBUZUAOOWSA-MRXNPFEDSA-N
MW504.01 g/mol
LogP3.01
Rot. Bonds5

About (3R)-N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(5-methyl-1H-indazol-7-yl)sulfonyl]pyrrolidine-3-carboxamide

(3R)-N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(5-methyl-1H-indazol-7-yl)sulfonyl]pyrrolidine-3-carboxamide (PubChem CID 171442744) has the molecular formula C23H26ClN5O4S and a molecular weight of 504.01 g/mol. Its IUPAC name is (3R)-N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(5-methyl-1H-indazol-7-yl)sulfonyl]pyrrolidine-3-carboxamide.

Molecular Properties

Compound Name(3R)-N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(5-methyl-1H-indazol-7-yl)sulfonyl]pyrrolidine-3-carboxamide
PubChem CID171442744
Molecular FormulaC23H26ClN5O4S
Molecular Weight504.01 g/mol
Exact Mass503.14
IUPAC Name(3R)-N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(5-methyl-1H-indazol-7-yl)sulfonyl]pyrrolidine-3-carboxamide
SMILESCc1cc(S(=O)(=O)N2CC[C@@H](C(=O)Nc3ccc(N4CCOCC4)c(Cl)c3)C2)c2[nH]ncc2c1
InChIInChI=1S/C23H26ClN5O4S/c1-15-10-17-13-25-27-22(17)21(11-15)34(31,32)29-5-4-16(14-29)23(30)26-18-2-3-20(19(24)12-18)28-6-8-33-9-7-28/h2-3,10-13,16H,4-9,14H2,1H3,(H,25,27)(H,26,30)/t16-/m1/s1
InChIKeyOQOHBUZUAOOWSA-MRXNPFEDSA-N
XLogP3.01
TPSA107.63 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds5
Heavy Atoms34
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500504.01
LogP ≤ 53.01
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_A(478)', 'substructure': 'N/A'}

Analyze (3R)-N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(5-methyl-1H-indazol-7-yl)sulfonyl]pyrrolidine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (3R)-N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(5-methyl-1H-indazol-7-yl)sulfonyl]pyrrolidine-3-carboxamide?
The IUPAC name of (3R)-N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(5-methyl-1H-indazol-7-yl)sulfonyl]pyrrolidine-3-carboxamide (CID 171442744) is (3R)-N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(5-methyl-1H-indazol-7-yl)sulfonyl]pyrrolidine-3-carboxamide.
What is the SMILES notation for (3R)-N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(5-methyl-1H-indazol-7-yl)sulfonyl]pyrrolidine-3-carboxamide?
The canonical SMILES for (3R)-N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(5-methyl-1H-indazol-7-yl)sulfonyl]pyrrolidine-3-carboxamide is Cc1cc(S(=O)(=O)N2CC[C@@H](C(=O)Nc3ccc(N4CCOCC4)c(Cl)c3)C2)c2[nH]ncc2c1.
What is the InChIKey of (3R)-N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(5-methyl-1H-indazol-7-yl)sulfonyl]pyrrolidine-3-carboxamide?
The InChIKey is OQOHBUZUAOOWSA-MRXNPFEDSA-N. The full InChI is InChI=1S/C23H26ClN5O4S/c1-15-10-17-13-25-27-22(17)21(11-15)34(31,32)29-5-4-16(14-29)23(30)26-18-2-3-20(19(24)12-18)28-6-8-33-9-7-28/h2-3,10-13,16H,4-9,14H2,1H3,(H,25,27)(H,26,30)/t16-/m1/s1.
What are the key properties of (3R)-N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(5-methyl-1H-indazol-7-yl)sulfonyl]pyrrolidine-3-carboxamide?
(3R)-N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(5-methyl-1H-indazol-7-yl)sulfonyl]pyrrolidine-3-carboxamide has a molecular weight of 504.01 g/mol, XLogP of 3.01, 5 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (3R)-N-(3-chloro-4-morpholin-4-ylphenyl)-1-[(5-methyl-1H-indazol-7-yl)sulfonyl]pyrrolidine-3-carboxamide is sourced from PubChem (CID 171442744), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).